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ASSESSING THE DERMATOLOGICAL HEALTHCARE NEEDS OF  
TODAY’S GERIATRIC POPULATION; A NATION-WIDE  
BEHAVIORAL ANALYSIS 
 
RYAN THOMAS SHAW 
 
ABSTRACT 
The geriatric population (65 years or older) represents a large portion of dermatology 
patients and is growing rapidly. This population is hypothesized to face several 
exacerbated barriers to dermatological healthcare, often resulting in the deferral of 
necessary dermatological healthcare. This avoidance behavior unnecessarily increases 
morbidity and mortality of this population due to dermatological diseases. The behaviors 
of this group towards their dermatological healthcare must be assessed for public policy 
to help fix the disparity seen in their dermatologic care. 
A cross-sectional online survey was carried out among a randomly selected sample of 
609 registered SurveyMonkey® users aged 65 years or older across the continental 
United States. Multiple linear regression analysis of the data revealed a negative 
relationship between perceived barriers to care and self-reported usability of telemedicine 
(p=0.01). This analysis also revealed several gender differences; females were more 
likely to be concerned with “cosmetic/aging” (p<0.0001) and males reported both higher 
prevalence of skin cancer (p<0.005) and higher concern for developing skin cancer 
(p=0.05).  
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INTRODUCTION 
Dermatological pathologies affect more than 85 million Americans yearly and 
represent a financial burden comparable with or exceeding other diseases of significant 
public health concern.9,32 Many of these conditions affect people over 65 years of age at a 
higher rate, often due to accumulated ultraviolet (UV) radiation and a declining immune 
system. Of those affected, elderly patients also present with significantly more diagnoses 
than younger individuals (2.2 vs. 1.6 per person). With this obvious increased 
dermatological disease burden in the elderly, extra attention needs to be paid to the skin 
of the geriatric patient.  
Americans 65+ are currently the fastest-growing cohort, yet no previous research 
has been done to evaluate the behavior of this group concerning their dermatological 
health.45 This population is believed to perceive elevated barriers to care, specifically in 
dermatology.44 For these, and other reasons, geriatric patients tend to defer care for their 
dermatological diseases, unnecessarily increasing morbidity of these diseases in the 
geriatric population. Therefore, the dermatological healthcare needs of the geriatric 
population must be assessed to improve access to care. 
 
SKIN 
As an organ, the skin’s primary function is as a barrier separating the outside 
world from our internal environment. The normal structure of the skin is composed of 
two functionally distinct layers, the outer epidermis, and the deeper dermis. The 
epidermis is in direct contact with the outside world. It is avascular and lacks innervation 
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but does have several features to deter environmental assaults and to contain our internal 
media. The epidermis is described histologically as a keratinizing epithelium; it is formed 
and maintained by continual replication and subsequent terminal differentiation of basal 
keratinocytes. Apoptosis of these cells occurs as they are pushed apically by this 
proliferative growth. Strong desmosomal connections between keratinocytes contribute to 
the skin’s mechanical integrity and keep cells connected even after death. Specialized 
intracellular lipids and proteins, collectively known as the cornified cellular envelope 
(CE), are released upon cellular death, coating the layers of dead keratinocytes (stratum 
corneum, SC) and conferring water-impermeability to the skin..40,52 The dermis is less 
cellular, exhibits more fibers, usually as collagen bundles, and is innervated and 
vascularized.  
Because of its location, the skin is constantly exposed to both, intrinsic (e.g. 
reactive oxygen species, ROS, free radicals) and extrinsic factors. Ultraviolet (UV) 
radiation is among these extrinsic factors and is the leading cause of skin cancer.4  
Symptoms of many systemic diseases are observable in the skin because of its 
location at our exterior.46 An example of this is a visible yellowing of the skin, known as 
jaundice; this occurs due to excess levels of circulating bilirubin, a byproduct of 
erythrocyte metabolism, and is an indicator of several pathologies. Many systemic 
diseases have characteristic cutaneous symptoms like this and should be monitored for in 
the geriatric population. Understanding this connection between the skin and systemic 
health helps comprehend the importance of regular skin exams to the overall health of the 
geriatric patient.  
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AMERICA’S AGING POPULATION 
America’s aging population is a topic consistently at the forefront of modern 
healthcare debate. The number of Americans aged 65 years or older is expected to more 
than double the 2016 census’ reported population of 46 million to 98 million people by 
the year 2060, representing a percent population change from 15% to 24%.9 This 
population shift on the horizon is of increased importance to the dermatological field 
because of the large proportion of their patients that this population represents.  
Trichotomization of the geriatric population by age (65-74, 75-85, 85+) is a trend 
that was noticed throughout the literature and will be carried over into this study. This 
division helps conceptualize the burden of disease in the elderly. 
UNDERREPRESENTATION 
The elderly are also substantially underrepresented in public health monitoring 
surveys due to participant nonresponse.14 Those that do reply are believed to exhibit high 
rates of baseline bias, failing to provide a complete medical history, and this is also 
believed to increase with age. Past studies have found higher rates of nonresponse in 
elderly patients with poor lifestyle choices and overall poorer health; it is, therefore, 
likely that this population is largely underrepresented.6,25   
 
MECHANISM OF AGING 
The skin’s process of aging represents a composite of two entities in itself, 
intrinsic and extrinsic aging.4 Intrinsic aging is thought of as “natural” aging because it is 
	4 
the same process experienced by other cells in our body.35 Extrinsic aging is a result of 
the skin’s interaction with the external environment; it is associated so strongly with UV-
exposure that it is often referred to in the literature and more so in the popular media 
simply  as “photoaging.”52 Smoking and environmental pollution are two more recently 
discovered extrinsic factors of skin aging but represent such a minimal part in the 
process, especially compared to UV-exposure, that they are rarely considered.4,8 Results 
of intrinsic aging alone usually do not appear before 70 years of age, so visible aging can 
almost entirely be attributed to extrinsic aging.4  
 CONTRIBUTING FACTORS 
Chronic UV exposure due to sunlight is the major contributing factor to premature 
skin aging.30 When this radiation energy enters this skin it can react with DNA or other 
endogenous photosensitizer molecules. UV photons are directly absorbed by DNA, 
causing structural changes and eventually mutations if not repaired by intracellular 
mechanisms. Other photosensitizer chromophores in the skin can absorb these photons 
and spare DNA damage.23 These molecules are excited in the process and subsequently 
react with O2 to produce reactive oxygen species. These ROS destroy interstitial collagen 
and also regulate enzyme levels that further contribute to matrix degradation of the skin.30  
 Atherosclerosis, diabetes mellitus, human immunodeficiency virus (HIV), and 
congestive heart failure are systemic diseases associated with an increased risk in 
dermatological disease development.41,43 Their contribution to the development of skin 
diseases is secondary to their effects on reducing blood flow or immune function.41 These 
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diseases are all also more prevalent in the elderly population and so, accordingly, they are 
contributing factors to the age-dependency of skin disease.  
Increased use of pharmaceuticals also contributes to the higher prevalence of 
dermatological diseases seen in the geriatric population. Medications used to treat 
hypertension (HTN) and cardiovascular disease (CVD) are specifically notorious for 
causing pruritis and xerosis in the geriatric population.33 A more general problem is the 
increased incidence of drug hypersensitivity reactions, adverse drug reactions that range 
in severity from mild to severe. Symptoms of these reactions are rashes, anaphylaxis, and 
serum sickness. Significantly increased polypharmacy in this population also makes it 
difficult to determine which drug or combination of drugs is the causative agent. 
Additionally, the lack of effective alternative therapies may hinder changing medication. 
HISTOLOGICAL CHANGES 
Cross-sectional skin samples from elderly patients are easily distinguishable from 
those of young patients; samples from elderly patients exhibit visible thinning of both the 
epidermis and dermis, decrease in basement membrane lipids, and reduced vascularity.24  
The thickness of the stratum corneum (SC) is largely maintained throughout life, but the 
integrity of its barrier function does decline with age.16,54 Rete pegs, epithelial extensions 
that project into the underlying connective tissue, may also be reduced, a process that is 
believed to be the primary factor in epidermal thinning. Surface lipids decrease with age, 
thinning the stratum corneum’s lipid film.5,53  
 CLINICAL MANIFESTATIONS 
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 These histological changes are a more recent discovery, and extensive research is 
necessary for a complete understanding of their development, but the clinical 
manifestations of these changes have been extensively documented. Regular complaints 
of the elderly patient are "dry skin," "itching," "wrinkling," "dyspigmentation," "easy 
bruising," increased susceptibility to insult and reduced healing function.3,4 Pruritus, 
when not secondary to xerosis or cutaneous insult, is often the result of an inappropriate 
peripheral nervous system response to histamine in the elderly patient.57 The increase 
seen in other complaints is usually attributable to the processes of aging previously 
described. 
Dermatological diagnoses exhibiting increased morbidity in the elderly include 
psoriasis, alopecia areata, urticaria, fungal infections, decubitus ulcers, skin cancer, and 
precancerous lesions (actinic keratoses and lentigo maligna).22 These diseases affect 
patients daily quality of life and can be deadly.  
Effects of extrinsic and intrinsic aging are easily studied separately by comparing 
areas of skin protected from the sun with those usually exposed, such as the face or 
dorsum of the hand. Photoaged skin is characterized by wrinkles, laxity, increased 
fragility, easy blistering, a leathery appearance, and decreased wound healing function.30 
Intrinsically aged skin is also lax but maintains a smooth texture.  
Hair and nail changes also occur with age and are particularly detrimental to 
patients’ psychological wellbeing. Hair loses its pigment, graying with age, as melanin 
production decrease in the hair follicle.28 Hair also becomes thinner and more diffuse as 
individual strands become narrower and follicles spend proportionally more time in the 
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resting phase, telogen. Nails usually become thin and brittle but may thicken in response 
to repeated trauma. Brittle nails are easily broken and thickened nails are at increased risk 
of becoming ingrown.2 Dystrophic nails are at an increased risk of developing fungal 
infections like onychomycosis, further complicating care for the geriatric patient’s nails. 
These hair and nail changes are another reminder of patients’ age and cause considerable 
anxiety in those affected. 
 
COSMETIC TREATMENTS 
Our society reacts differently to dermatological disorders than to other systemic 
diseases. Whereas the latter receives understanding sympathy, dermatological conditions 
often provoke aversive behaviors that lead to feelings of stigmatization in the 
affected.18,37 Aging results in a change of physical appearance which sometimes also 
leads to aversive reactions 
America is a youth-centric society; being young is an ideal and deterring from this 
causes many people distress.  “The Social Skin” is a recent concept proposed by social 
biologists to help make sense of the differential psychological behavior exhibited by 
individuals in response to aging. This idea attempts to think of the skin in light of its 
function in emotional expression and is contrasted with an older idea, “The Biologic 
Skin.”29 Through aging the person staring back in the mirror is transfigured and thereby 
our psyche is also altered, resulting in distress. This concept will not be discussed further, 
but its investigation is recommended to those having trouble understanding these 
psychological effects of aging.  
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With age, the skin declines in appearance and texture and may cause 
psychological discomfort in people as a constant reminder of the burden of age. Cosmetic 
treatments to correct for these changes may alleviate this psychological distress and boost 
self-esteem.29 The number of cosmetic treatments performed annually has increased in 
recent years; people like these procedures and the effects they achieve.39 More 
individuals may be interested in these cosmetic procedures yet they defer treatment due 
to societal implications. Mood disorders, elevated in the geriatric population, may even 
be improved by the psychological effect of these treatments. The behavior of the geriatric 
population regarding cosmetic procedures at the dermatologist office is a topic with no 
published data, so exploratory research is recommended; societal misconceptions should 
be addressed if the population at large would benefit. 
  
SKIN CANCER 
Skin cancer is the most common malignancy in the United States, affecting more 
than 3 million Americans yearly.20,47 The two most common types of skin cancer are 
melanoma and non-melanoma skin cancer (NMSC). Melanoma is a malignancy 
originating in melanocytes of the epidermis. NMSC originates in keratinocytes of the 
epidermis and comprises two subcategories, basal cell carcinoma (BCC) and squamous 
cell carcinoma (SCC). These diseases increase in burden throughout the human lifespan, 
most substantial in those over 75 years of age.13  Avoidable UV-radiation is responsible 
for most skin cancers, directly causing over  90%.17 Not considering wounds, burns, or 
cutaneous infection, skin cancer is responsible for almost all skin disease-related deaths, 
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of which about two-thirds are due to melanoma.32 These malignancies are the frequent 
targets of public policy in dermatology due to their highly preventable nature.21,50  
Several factors have been shown to affect skin cancer prognosis. Interestingly, 
patients with an established dermatologist have been shown to present with shallower 
melanomas at time of diagnosis compared with individuals without one.36 This benefit 
persists despite length since last dermatologist visit, so educational information attained 
at the patient’s first office visit is thought to mediate these differences. With a significant 
increase in self-diagnostic ability after one office visit, one can only imagine the 
improvements more substantial preventative care measures in dermatology could make 
for the geriatric population. 
 
BARRIERS TO CARE 
Health insurance source, age, gender, race/ethnicity, and geographic location are 
all factors that have been shown to correlate with recent dermatologist office visits.38 
Dermatological conditions are usually easily diagnosable with minimal invasion, yet the 
elderly are historically reluctant to consult a medical provider for diagnosis and 
treatment. Previous studies have found elevated perceived barriers to care in the geriatric 
population, such as “doctor not responsive to concern” and “fear of discovering serious 
illness”.11 These modifying factors have not been explicitly evaluated in the dermatologic 
field but may help explain some of this reluctance and the resulting deferral of care.11 
Accessibility of dermatological care has emerged as a recent epidemic, mainly 
due to a simultaneous workforce shortage and an increase in patient load.27 This problem 
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is seen universally but is significantly more severe in areas exhibiting lower 
dermatologist density.58 This recently increased patient load is primarily due to the 
growing elderly population, and the recent expansion of healthcare to an additional 16 
million people via the Affordable Care Act (ACA).43 Increased demand due to healthcare 
expansion is transitory and will resolve, but the unproportionate dermatological 
workforce growth compared to the demand that is posed by the aging American 
population has no foreseeable resolution and represents a real barrier to care. The 
outcome of this is generally increased wait times for dermatology appointments.34 This 
barrier is substantial; reduced density of dermatologists has been shown to affect the 
outcome of melanoma prognoses negatively.10  
This influx of patients during a dermatological care deficit presents several 
problems for the reasons described above. The dermatologic healthcare needs of the 
geriatric population have not been sufficiently assessed, making it difficult to plan for the 
increased load that this population transition will place on the dermatological workforce. 
Several options exist to help fortify the field of geriatric dermatology, but further research 
is needed to decide which is of most potential benefit. Telemedicine is one of these 
options but not enough is known about technological savviness of the geriatric population 
to determine whether they could operate the rather involved equipment specific to the 
dermatologic niche.26 Assessment of these abilities will provide the medical community 
with information to improve quality of care to this generation and reduce the age-related 
dermatological health care disparity. 
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TELEDERMATOLOGY 
Telemedicine has emerged as a likely candidate to help reduce dermatological 
health care disparity. A recent study on teledermatology shows promise in improving 
access to and price of dermatologic care but emphasizes that this is not always the case.31 
In comparing the relative success of several teledermatology programs, effective 
preselection, high-quality images, use of dermatoscopy for pigmented lesions, and having 
adequate infrastructure and culture in place were factors associated with a successful 
outcome of teledermatology programs. The absence of any of these factors drastically 
lowers success. Teledermatology applications have been proven to increase the 
diagnostic ability for PCPs and thus show great promise in extending care, especially to 
areas of decreased dermatologist density.26,31,49,56  
 
PRESENT STUDY 
 Today’s aging population necessitates research on the dermatological healthcare 
needs of the geriatric population. The elderly is believed to face several additional or 
exacerbated barriers to dermatological health care and often choose to defer treatment in 
response, unnecessarily increasing morbidity and mortality of dermatological diseases. 
This study will attempt to assess the dermatologic healthcare behavior of the population 
over 65 years of age to determine what needs to be done by the dermatological 
community to help close the current gap in dermatological care. 
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Specific Aims 
In a time of rapidly changing logistics within the medical field, it is important that we 
consider the needs of all people in order to be able to improve healthcare for all. Little 
research has been done in inquiry of the dermatological needs of the geriatric population 
(65+). In order to allow these needs to be accounted for, we will: 
1. Identify chief dermatological complaints and previous diagnoses of this group. 
2. Identify any barriers to care for this group of people, whether physical or 
psychological. 
3. Identify respondents’ location and provider preferences for dermatological care. 
4. Use gathered information to update guidelines used in dermatological healthcare 
of this group if warranted. 
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METHODS 
 
 This study utilized a 15-question survey (Appendix I) as its sole source of data. 
An online survey platform, SurveyMonkey®, was used to gather completed questionnaire 
data. The study sample was chosen randomly from the SurveyMonkey® user database. 
Parameters for inclusion were: United States resident aged 65 years or older. Age 
balancing was controlled to be representative of USA census data.9,42  
In anticipation of data analysis, the sample size needed for sufficient confidence 
was calculated. The minimum sample size needed was calculated to be 385 people with 
the equation in Figure 1, using the population size (N) of the USA (327 million), 
confidence level (Z) of 95%, and margin of error (e) of 5% (Fig. 1).48 Actual sample size 
(611) was determined with the study budget as the limiting factor, to allow for the 
smallest margin of error and to allow for incomplete responses if necessary.  
 
Figure 1. Sample Size Determination 
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PROCEDURE 
 The survey used in this study was created and optimized through a series of steps. 
An initial literature review of the topic of interest, the dermatologic healthcare behaviors 
of the population over 65 years old, was performed to determine what information was 
missing. Searching the popular media helped shed light on which of these topics was 
currently of most relevance and a proceeding group meeting helped arrive at an initial 
survey. Two separate and sequential beta tests of 50 respondents each were performed 
using the SurveyMonkey® platform to assess the usability of the survey and identify any 
missing popular answers to survey questions. This study values increased reliance on 
recognition (as opposed to recall) in an attempt to reduce recall bias and streamline 
analysis.7,19 The survey was edited after each beta test to increase comprehension and 
usability. 
This study posed minimal risk to participants and was approved with exempt 
status by the Boston University Institutional Review Board. Participants of the study self-
administered the survey using the SurveyMonkey® online platform. The “Research 
Information Sheet” (fig.2) was used as a header for the survey, visible throughout the 
completion, to obtain informal informed consent necessary for exempt research and to 
inform participants to this risk as well as other aspects of the study deemed essential or 
beneficial to the participants. 
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Figure 2. Research Information Sheet 
 
 
 THE SURVEY   
Basic demographic information questions were the first to be formulated; this 
information included age, gender, geographic location, and dermatologic health history. 
Behavioral evaluation questions were next; of interest was how respondents find 
healthcare providers, how they get to medical appointments, their primary source of 
dermatologic information, where they do or would get care for their skin conditions, and 
any concerns they have concerning their dermatologic health. 
Level of reliance this population has on online reviews in deciding on which 
healthcare provider to choose emerged early in group discussion as a relevant topic and 
was included as a question. What barriers to dermatologic care this population faces also 
came up in discussion and was included.  
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Recent literature has revealed a trend of better melanoma prognoses in patients 
with an established dermatologist, and so inquiry of whether the respondent has an 
established dermatologist was included to assess the impact of these recent findings.10,36  
As previously discussed, teledermatology represents a possible answer to 
improving access to care, but dermatoscopic usability by the geriatric population is 
unknown. Telemedicine usage ability is simply polled (yes/no) in the survey, as more 
detailed questions are likely to be misunderstood by the population being studied. 
 
DATA ANALYSIS  
  
 Participant demographic information (age, income, gender, and location) and 
response data collected in the survey will first be coded. The sample population will be 
trichotomized by age (65-74, 75-64,85+ years old) to allow identification of age-related 
trends. Two multivariate analyses will be completed, one investigating participant 
reported teledermatology usability ability by age, gender, household income, region, and 
perceived barriers to care and another investigating participant complaint of cosmetic 
concerns by age, gender, income, region, and if their last dermatologist office visit was 
for cosmetic reasons.  Skin cancer prevalence, as well as concern for its development, 
will be evaluated with two additional multivariate analyses to assess correlation either has 
with gender, household income, and geographic location. 
 With sourcing information on the dermatological health care behavior of the 
population over 65 years old as the primary goal of this study, a portion of the questions 
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included are simply investigative. Actual results of these questions will be presented to 
allow for a complete discussion of this population's behaviors and needs. 
	18 
RESULTS 
` The survey was completed by 611 respondents. Two data sets were omitted 
because they did not meet the age parameter (65+); these individuals are believed to have 
had false age data in their SurveyMonkey® profiles or to be using another person's 
account. Survey abandonment rate was 20%, and the average completion time was 3 
minutes, 56 seconds. The response rate was higher for females as compared to males, but 
it is only significant for individuals 65-74 years of age (fig.3). 
 
Figure 3: Sample Population Age and Gender 
The final sample of 609 was analyzed as described above. In cases where multiple 
answers were written in for questions asking for the choice most relevant to the 
respondent, the first answer written was accepted as the complete answer. If, however, a 
consensus on primary answer could not be definitely made, answer choice of “other” was 
retained. 
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TELEMEDICINE 
Perceived barriers to care displayed a significant relationship with reported telemedicine 
usability (linear regression, p=0.01, R²=0.0267). People who reported non-usability of 
telemedicine were more likely to report barriers to dermatological care (36.5%) than 
people who reported usability (26%). Other factors assessed (age, gender, household 
income, geographic region) did not display a significant relationship with telemedicine 
usability. 
COSMETIC CONCERN 
 Linear regression revealed a significant relationship between respondents’ gender 
and concern with “Cosmetic/aging” (p<0.0001, R²=0.0582), with significantly more 
women (70.6%) than men reporting these concerns. Other factors assessed (age, 
household income, and if their last dermatologist visit was for cosmetic reasons) did not 
display a significant relationship with concern for “cosmetic/aging.” 
SKIN CANCER  
Concern for developing skin cancer was found to be significantly associated with 
gender (p=0.05, R²=0.0202), with males exhibiting more concern than females (48.9% 
vs. 31.6%). The other factors assessed (age, geographic area, and household income) did 
not display a significant relationship with concern for developing skin cancer. 
 Males in the sample had a significantly higher frequency of being previously 
diagnosed with skin cancer or related diagnosis than females (linear regression, p<0.005, 
R²=0.0315).  Of those studied, 39% of males and 28.9% of females reported a history of 
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such diagnoses. The other factors assessed (age, geographic location, and household 
income) did not display a relationship with a history of skin cancer or related diagnosis. 
 
RESPONSE DATA 
 Of those who responded, 313 (51%) had an established dermatologist, and 296 
(49%) did not. No previous data on a population-wide frequency of geriatric patients with 
an established dermatologist could be found in the literature, but interestingly this 
statistic is almost the same as the frequency (50.5%) of patients with an established 
dermatologist reported in a recent study of patients presenting with melanomas in 
clinic.36 
 More than half (353; 58%) of respondents reported asking their PCP for a referral 
when choosing a healthcare provider. Minority answers were asking family or friends 
(95; 16%), other (60; 9.9%), searching the internet (54; 8.9%), and health insurance 
website (47; 7.7%). 
 Most (529) reported driving themselves to medical appointments (fig.4). Other 
reported methods were riding with friends/family (32), walking or biking (15), non-
emergency medical transportation (NEMT, 12), and public transportation (8). 13 people 
responded “other”, of which the majority were a combination of several above methods; 
“ride share” and “car service” are two responses worth noting but with only one 
respondent each. 
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Figure 4: Response data to question 2. 
  
When asked about barriers to dermatological care they face, 405 respondents 
(67%) reported facing no such barriers (Fig. 5). The most significant barrier was out of 
pocket expenses, reported by 66 people (10.8%). This was followed by 42 people (6.9%) 
whom reported deterring care because the issue did not seem serious to them. “Other” 
was selected by 34 people (5.6%), most of whom seem to have been confused by the 
question because a nonsensical answer was written in. Long wait time to get an 
appointment was the next most popular response with 24 people (4%). Twenty-one 
people (3.4%) reported deferring care due to a previous experience in which their 
complaint was not taken seriously. Minority answers were “fear of unnecessary tests or 
treatments” (7 people), “transportation problems” (4 people), “Don’t want to take time 
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off work” (3 people), “Fear of discovering a serious illness” (2 people), and “Unsafe 
neighborhood where I live or get medical care” (1 person).  
 
Figure 5: Response data to question 3. 
  
Dermatologists were the most relied on source for medical information on 
dermatological conditions, with 270 people (44%) citing them as their primary source 
(Fig. 6). PCPs were the next, used by 216 people (36%). The internet provided this 
information for 75 respondents (12%). Minority answers were “Other” (45 people; 4%), 
“Ask Family/Friends” (25 people; 3%), and “Pharmacist” (4 people; 1%).  
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Figure 6: Response data to question 4. 
 
Reason for the last dermatologist office visit for 191 respondents (31.4%) was for 
a routine skin check (Fig.7). “Suspicious/changing lesion” was the reason for last 
dermatologist visit for 121 respondents (19.9%). “Other” was the reason for 53 people 
(8.7%).  “Rash” was the reason for 34 people (5.6%). Minority answers were “Cosmetic 
reasons” (13 people; 2.1%), “Psoriasis” (12 people; 2%), “Hair disorders” (9 people; 
1.5%), and “Nail disorders” (4 people; 0.7%). One hundred seventy-one people had never 
been to a dermatologist. 
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Figure 7: Response data to question 6. 
 
 Most respondents were averse to telemedicine (Fig. 8); 389 respondents (63.9%) 
reported non-usability, of which 371 indicated that they would prefer to go to the doctor 
and 18 indicated they would not be able to use the technology. People willing to use 
telemedicine numbered 221 (36.2%). 
 
Figure 8: Response data to question 9. 
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Of the sample chosen, 391 people (64.2%) reported having been previously 
diagnosed with a dermatological condition. Table 1 summarizes response data and shows 
the prevalence of each diagnosis. Basal cell carcinoma (BCC) was the most prevalent 
with 107 people (17.6%) reporting a previous diagnosis. Two hundred eighteen people 
reported no history of dermatological diagnosis. 
Table 1: Dermatological disease history 
Disease previously diagnosed with # people  
Prevalence 
(n=609) 
BCC 107 0.175697865 
Seborrheic Keratoses 78 0.128078818 
Eczema 75 0.123152709 
Rosacea 54 0.088669951 
SCC 52 0.085385878 
Other (specify)  49 0.08045977 
Acne 43 0.070607553 
Onychomycosis 35 0.057471264 
Herpes Zoster 33 0.054187192 
Melanoma 34 0.055829228 
Skin cancer but unsure which type 32 0.052545156 
Pruritus  29 0.047619048 
Psoriasis 28 0.045977011 
HSV 26 0.042692939 
Tinea Pedis 23 0.037766831 
Actinic Keratoses 21 0.034482759 
Alopecia 19 0.031198686 
Ulcer 5 0.008210181 
Vitiligo 2 0.003284072 
Candidiasis 1 0.001642036 
Pemphigus 0 0 
 
 Table 2 summarizes response data concerning respondents' dermatological health 
concerns. A majority of respondents (547 people; 90%) had concerns with their 
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dermatological health. Most concerned about were "aging/cosmetic" and "developing 
skin cancer," reported by 297 (48.8%) and 219 (36%) people, respectively. 
Table 2: Dermatological concerns of sample 
Dermatologic concerns  # people 
Prevalence 
(n=609) 
Aging/Cosmetic 297 0.487684729 
Developing Skin Cancer 219 0.359605911 
Pruritus/itching 139 0.228243021 
Hair Loss 134 0.220032841 
Suspicious/changing mole 129 0.21182266 
Skin Discoloration  62 0.10180624 
Viral infection 39 0.064039409 
Other (specify) 31 0.05090312 
None 31 0.05090312 
 
 Respondents’ preferred location for dermatological treatment is summarized in 
Fig. 9. Dermatologist offices are used by 313 respondents (51.4%). Of these people, 289 
see a dermatologist in private practice and 24 in a hospital setting. PCP offices are used 
by 249 people (40.9%). Of the remaining sample, 35 people (5.7%) selected “Other”; 5 
people (0.8%), “MedSpa”; 4 people (0.7%), “Telemedicine”. 
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Figure 9: Response data to question 10. 
 Provider preference for dermatological care of the sample population is 
summarized in Fig. 10. Dermatologists were preferred by 419 people (68.8%), nurse 
practitioners by 25 people (4.1%), and physician assistants by 18 people (3%). The 
remaining 147 people (24.1%) had no preference for provider. 
 
Figure 10: Response data for question 11 
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Response data regarding the training of respondents last dermatological care 
provider can be visualized in Fig. 11.  Dermatologists (MD/DO) were the provider for 
351 (74%) of respondents’ previous dermatology visit; Physicians assistants, 42 (6.9%); 
Nurse practitioners, 31 (5.1%); Both a dermatologist and NP/PA, 20 (3.3%). One 
hundred sixty-five people (27.1%) did not remember the training of their last 
dermatology provider.  
 
Figure 11: Response data for question 12  
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DISCUSSION 
 
 The purpose of this study was to evaluate the dermatological healthcare needs of 
the geriatric population. These needs are of significant interest because this population 
makes up a substantial portion of dermatological patients. These needs were evaluated by 
analyzing the behavior of this population towards dermatological health and assessing 
any discrepancies between the behaviors observed and what should be expected.   
The data revealed an interesting relationship between telemedicine usability and 
self-reported barriers to dermatological care in which people reporting they would use 
telemedicine had a lower prevalence of barriers (26% vs. 36.5%). This is opposite to 
what was expected; it was theorized that people experiencing barriers to care would be 
more inclined to use telemedicine to increase access to care. In context, these results can 
likely be attributed to differences in psychological effect, with those possessing a more 
central locus of control displaying less perceived barriers and also willing to use new 
technology, and those with a more external locus of control experiencing more barriers 
and less likely to embrace new technology. The regression model used to predict 
telemedicine usability in the geriatric population displayed poor predictability 
(R²=0.0267), likely because of confounding variables. Further research is needed to 
reveal stronger predictors.  
The expected relationship between cosmetic concern and gender was verified by 
linear regression; significantly more females reported a concern with “cosmetic/aging.” 
Gender differences ingrained in American culture are likely responsible for this observed 
	30 
relationship.  This model displayed relatively poor predictability(R²=0.0582), accounting 
for only about 6% of the variance.  
Gender was the only tested factor found to be significantly associated with either 
concern for developing skin cancer or a history of skin cancer or related diagnoses. Males 
in the sample population are more concerned about developing skin cancer than women 
(31.6% vs. 48.9%). Prevalence of these malignancies was also found to be higher in 
males than females (39% vs. 28.9%). Both of these models displayed poor predictability 
(R²<0.04), most likely because many other factors are at play. Contemplation of these 
results reveals a possible cause and effect relationship in which men develop more 
malignant lesions and are therefore more concerned with their development. 
Results on how our patients choose new medical providers was different from our 
expected result. The vast majority reported they would ask their PCP for a referral, with 
several minor categories trailing far behind. It was theorized that today’s geriatric 
population is more technologically adept than previous generations, so increased reliance 
on the internet for this process was expected. Internet usage was reported by only 8.9% of 
respondents, however.  
Response data on method of transportation used to get to medical appointments 
was also not as expected; the majority (87%) reported they drive themselves to 
appointments. This frequency was predicted to be around 60% based on data from a 
previous study that found the incidence of elderly patients who drove themselves to 
medical appointments to be just under 60%.12 Results of this other study are a more 
reliable account of patients transportation methods because are based on patients actual 
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behaviors and not their perceptions of what “usually” happens. The statistic found in this 
study will be more indicative of the percentage of geriatric patients who can drive 
themselves to medical appointments if needed. 
The infrequency of barriers to dermatological care reported by the sample can be 
considered an overall positive. Rates may, however, be significantly higher due to 
response bias (respondents may believe they don’t need to go to the dermatologist or that 
they see one frequently enough). One may even argue that the response “Nothing, I don’t 
go to a dermatologist” by an individual over 64 years old is a barrier in itself. Financial 
problems are the only barrier with previous data in the literature; previous studies have 
reported prevalence (11%) of this barrier almost identical to that seen in this study 
(10.8%).11,51 This correspondence helps prove the validity of this study and hints at a 
possible more general set of barriers to care shared by dermatology, primary care, and 
possibly other specialties. The new variables explored in this study help further elucidate 
barriers to dermatological care for the elderly.  
 That only 51% of respondents have an established dermatologist is unfortunate 
when considering the lack of this relationship is correlated with more invasive melanoma 
at the time of diagnosis.36. It is unclear how the logistics of this relationship work exactly, 
but patient education is believed to be the main factor since “time since last dermatologist 
visit” was not found to be a significant modifying factor. This educational knowledge 
should be isolated and made available to more patients, perhaps incorporated into 
geriatric primary care practice.  
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 Unsurprisingly, dermatologists were the most utilized source of information on 
skin conditions. This was expected due to the preference for dermatologists in the 
treatment of skin conditions seen in the general public.55 The frequency of 36% that 
reported using their PCP for this information was surprisingly high, especially 
considering that many of these people will be subsequently referred to a dermatologist for 
evaluation; perhaps PCPs play a sort of “middle-man” triaging role in this process, 
helping elderly patients get set up with dermatology appointments. The internet was used 
by only 12% of the sample population for this information. 
 Of the respondents who have been to a dermatologist before, “routine skin check” 
and “suspicious or changing lesion” were the most common reasons for their previous 
visit. Interestingly, these are the two reasons most pressed by public policy for being 
evaluated by a dermatologist; preventative health movements in dermatology such as the 
AAD’s “the ABCDEs of Melanoma” urge people to routinely self-check for changing 
lesions and visit a dermatologist for evaluation if they do find one.1 With 
disproportionally more skin lesions than the youth, the elderly may have increased 
distress caused by these dermatological preventative health measures.  Future studies 
should assess this distress in proportion to benefit and new preventative health measures 
should be instituted if the population would benefit. 
 Self-reported usability of telemedicine was lower (36.2%) than expected (~64%). 
This discrepancy can be mostly attributed to a preference for in-office doctor visits of this 
population. These results hint at a current geriatric population with the technological 
proclivity to use telemedicine but unwilling to change their ways. That few respondents 
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wouldn’t be able to use telemedicine helps maintain it as an option for improving access 
to care. This geriatric generation may not be open to embracing this new technology but 
they can be studied to prepare for future, more technologically adept generations.  
Survey questions on the dermatological concerns and previous diagnoses of the 
study population provided dermatological demographic information on the sample. 
Between these two sets of data, a potential gap in care can be observed as seen in the 
difference between the number of concerns and diagnoses for the same issue (ex. 
Pruritus; 139 concerned, 29 diagnosed). Respondents were allowed to choose multiple 
answers for both of these questions, so the precedence of other answer choices cannot 
explain this discrepancy. Hair loss is another condition exhibiting this discrepancy. These 
conditions, as well as concerns about them, are usually treatable and so these geriatric 
patients should consult the dermatological workforce for counseling or treatment to live a 
more enjoyable life. 
The number of people in the study population reporting a history of NMSC (BCC 
or SCC) was 135 (22.16%); epidemiological data from recent years estimates the lifetime 
prevalence of NMSC to be around 20% and on the rise.15 This correlation with national 
estimates helps further validate the study data. 
 Several questions collected data on preference of dermatological treatment 
location as well as provider. These preferences have recently emerged as popular topics 
in the literature, likely due to the influx and increased presence of physician extenders. 
Unsurprisingly dermatologists were preferred and were the last provider for most, but 
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they were not uncontended. PCPs were also preferred by a large percentage of people, 
further emphasizing their importance in dermatology.  
 A general shortcoming of this study is that it was done remotely via the internet. 
The population selected is possibly part of a smaller, more technologically advanced 
portion of the geriatric population and therefore not representative of the entire 
population. This method negates face to face contact and reduces respondent 
involvement. Respondents would likely have appreciated assistance with the technology 
used in this survey since technological savviness of today’s geriatric population is 
generally not good; reliability of survey data would likely have significantly increased if 
this interpersonal interaction could have occurred. This was, however, not possible; 
several options of delivering surveys in person were explored but eventually abandoned 
due to lack of foreseen efficacy.  
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RECOMMENDATION: Establishment of an age-appropriate dermatological 
healthcare intervention for patients in a primary care setting. 
 Survey results indicate that relatively few geriatric patients experience real 
barriers to dermatological care; most people get care if they think it is needed. The main 
problem causing a perpetual discrepancy in dermatological health care of the geriatric 
population seems to be a belief that such care is not needed. This way of thinking is likely 
acquired over the human lifespan as the societal assessment of dermatological diseases as 
less serious than systemic diseases is continually reaffirmed.  
Decreased depth of melanoma at diagnosis in patients having seen an established 
dermatologist proves the power that preventative health care measures can make in the 
dermatological field. Being focused on a superficial organ, dermatology stands to benefit 
largely from more preventative care measures. Informational materials from the 
dermatologist office with most significance should be selected and incorporated into PCP 
offices. At patients’ first wellness checkup of their 4th decade (roughly 40 years old), 
these materials, as well as best skincare practices, should be focused on.  
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APPENDIX I 
QUESTIONAIRE 
1. How do you usually find healthcare providers? 
Ask friends or family for referral  
Web search 
Referral by my primary care provider (PCP) 
Insurance website 
Other (please specify) 
*2. How do you usually get to medical appointments? 
I drive 
I get a ride from a friend or family member 
Public transportation 
Walk/bike 
Non-Emergency Medical Transportation (NEMT) 
Other (please specify) 
*3. What prevents you from getting the dermatological care that you need? 
Transportation problems 
Out of pocket expenses 
Previously having my concerns not addressed or deemed not serious by treating physician 
If the issue doesn’t seem urgent to you 
Long wait time to get an appointment 
Unsafe neighborhood where I live or where I get medical care 
Fear of discovering a serious illness 
Fear of unnecessary tests or treatments 
Don't want to take time off work 
Nothing, I see one regularly or when needed 
Nothing, I don't go to a dermatologist 
Other (please specify) 
*4. What sources do/would you use for medical information on skin conditions? 
Ask family/friends 
The internet 
My primary care physician (PCP) 
Dermatologist 
Pharmacist 
Other (please specify) 
*5. Do you have an established dermatologist?  
No 
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Yes 
*6. What was the reason for your last dermatologist visit? 
Suspicious or changing lesion/mole/spot 
Routine skin check 
Rash 
Psoriasis 
Bruising 
Burn 
Nail disorder  
Hair disorder 
Cosmetic reasons 
n/a (never been to a dermatologist) 
Other (please specify) 
*7. Select any dermatological conditions that you have been previously diagnosed 
with? (Please select all) 
Basal cell carcinoma 
Squamous cell carcinoma 
Melanoma 
Skin Cancer, but unsure which type 
Pruritus (itching) 
Tinea Pedis (athletes’ foot) 
Candidiasis 
Alopecia (hair loss) 
Psoriasis  
Eczema/Dermatitis 
Herpes Zoster (Shingles) 
Herpes Simplex (Cold sores) 
Pemphigus 
Seborrheic keratosis (age/liver spots) 
Actinic keratosis 
Vitiligo 
Rosacea 
onychomycosis (toenail fungus) 
An ulcer 
Acne  
None 
Other (please specify) 
*8. What concerns you have about your skin, hair, and/or nails? (select all that apply) 
Aging/cosmetic 
Itching 
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Developing skin cancer 
Viral infections (ex- shingles) 
Skin Discoloration 
Hair loss 
Suspicious or changing moles 
Other (please specify) 
*9. Telemedicine is a new technology that allows people to receive medical care from 
the comfort of their own home by uploading images and information about their 
symptoms. Would you use telemedicine? 
Yes 
No, I prefer going to the doctor 
No, I wouldn’t be able to use the technology 
*10. Where do/would you get medical care for your skin, hair and nail conditions? 
Medical Spa (MedSpa) 
Urgent Care or Emergency Room 
Primary Care Physician (PCP) 
Dermatologist at a Private practice 
Dermatologist at a hospital 
Telemedicine (online medical appointment) 
Other (please specify) 
*11. Who would you prefer to evaluate and treat your skin conditions? 
Board certified dermatologist (Medical Doctor) 
Dermatology nurse practitioner (NP) 
Dermatology physician assistant (PA) 
No preference 
*12. At your last dermatology visit, who evaluated and treated your skin conditions? 
Board certified dermatologist (Medical Doctor) 
Dermatology nurse practitioner (NP) 
Dermatology physician assistant (PA) 
Both a dermatologist and a nurse practitioner/physician assistant 
I don’t know the qualifications/training of my last dermatology provider 
*13. What is your age and gender? 
Male aged 65-69 
Male aged 70-74 
Male aged 75-79 
Male aged 80-84 
Male aged 85 or older 
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Female aged 65-69 
Female aged 70-74 
Female aged 75-79 
Female aged 80-84 
Female aged 85 or older 
Other (please specify) 
*14. What is your zip code? 
*15. Are online reviews likely to affect your decision making when choosing a 
healthcare provider? 
Yes 
No 
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